These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29096936)

  • 1. Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T; Yuki Y; Nakahashi R; Itoh H; Kiyono H
    Mol Immunol; 2018 Jun; 98():19-24. PubMed ID: 29096936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal vaccine development for botulinum intoxication.
    Fujihashi K; Staats HF; Kozaki S; Pascual DW
    Expert Rev Vaccines; 2007 Feb; 6(1):35-45. PubMed ID: 17280477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.
    Zaman M; Simerska P; Toth I
    Curr Drug Deliv; 2010 Apr; 7(2):118-24. PubMed ID: 20158484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanogel-based antigen-delivery system for nasal vaccines.
    Yuki Y; Nochi T; Kong IG; Takahashi H; Sawada S; Akiyoshi K; Kiyono H
    Biotechnol Genet Eng Rev; 2013; 29():61-72. PubMed ID: 24568253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
    Nochi T; Yuki Y; Takahashi H; Sawada S; Mejima M; Kohda T; Harada N; Kong IG; Sato A; Kataoka N; Tokuhara D; Kurokawa S; Takahashi Y; Tsukada H; Kozaki S; Akiyoshi K; Kiyono H
    Nat Mater; 2010 Jul; 9(7):572-8. PubMed ID: 20562880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of nanogel-based vaccines.
    Hernández-Adame L; Angulo C; García-Silva I; Palestino G; Rosales-Mendoza S
    Expert Rev Vaccines; 2019 Sep; 18(9):951-968. PubMed ID: 31487213
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in self-assembled nanogel delivery systems for immunotherapy.
    Tahara Y; Akiyoshi K
    Adv Drug Deliv Rev; 2015 Dec; 95():65-76. PubMed ID: 26482187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccines: wisdom from now and then.
    Kiyono H; Yuki Y; Nakahashi-Ouchida R; Fujihashi K
    Int Immunol; 2021 Nov; 33(12):767-774. PubMed ID: 34436595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
    Fujihashi K; Kiyono H
    Trends Immunol; 2009 Jul; 30(7):334-43. PubMed ID: 19540811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.
    Calderon-Nieva D; Goonewardene KB; Gomis S; Foldvari M
    Drug Deliv Transl Res; 2017 Aug; 7(4):558-570. PubMed ID: 28639138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.